GI
HRMY icon

GAMMA Investing’s Harmony Biosciences HRMY Stock Holding History

GAMMA Investing’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8K Buy
627
+126
+25% +$3.98K ﹤0.01% 2772
2026
Q1 		$14K Sell
501
-691
-58% -$22.7K ﹤0.01% 2892
2025
Q4 		$44.6K Sell
1,192
-254
-18% -$8.35K ﹤0.01% 2138
2025
Q3 		$39.9K Sell
1,446
-259
-15% -$8.92K ﹤0.01% 2143
2025
Q2 		$53.9K Sell
1,705
-1,224
-42% -$39.4K ﹤0.01% 1893
2025
Q1 		$97.2K Buy
2,929
+2,022
+223% +$72.5K 0.01% 1281
2024
Q4 		$31.2K Buy
907
+436
+93% +$15K ﹤0.01% 2018
2024
Q3 		$18.8K Buy
471
+189
+67% +$6.64K ﹤0.01% 2141
2024
Q2 		$8.51K Buy
282
+143
+103% +$4.3K ﹤0.01% 2331
2024
Q1 		$4.67K Buy
139
+44
+46% +$1.41K ﹤0.01% 2437
2023
Q4 		$3K Buy
+95
New +$2.65K ﹤0.01% 2441

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GAMMA Investing's HRMY Position: Q2 2026 in Review

GAMMA Investing increased its Harmony Biosciences (HRMY) stake by 25% in Q2 2026, buying an estimated $3.98K and bringing the position to 627 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

GAMMA Investing first reported a position in HRMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $97.2K in Q1 2025. 41 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • GAMMA Investing held 627 shares of Harmony Biosciences worth $22.8K as of Q2 2026.
  • GAMMA Investing bought 126 Harmony Biosciences shares in Q2 2026, an estimated $3.98K.
  • Harmony Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2772 holding.
  • GAMMA Investing first reported a position in Harmony Biosciences in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Harmony Biosciences position peaked at $97.2K in Q1 2025.
  • 41 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.